Dr. Natalie Dean is an assistant professor in the Department of Biostatistics at the University of Florida specializing in infectious disease epidemiology and study design. Her research focuses on innovative trial designs for evaluating vaccines targeting emerging pathogens, like Ebola, Zika, and COVID-19. She previously worked as a consultant with the World Health Organization on HIV drug resistance surveillance. Dr. Dean received her PhD in Biostatistics from Harvard University in 2014 and performed her postdoctoral work at the University of Florida. ​She has been active in science communications.